Acute Porphyria Drugs

R03AC12 - Salmeterol

Propably not porphyrinogenic
PNP

Rationale
Substrate for CYP 3A4. Probably insignificant metabolic load.
Chemical description
Adrenergic administered in asthma in inhalation aerosol, 50 µg/dose. Gives rise only to very low plasma concentrations. Metabolized in the liver (CYP 3A4) producing several metabolites.
IPNet drug reports
Uneventful use reported in 4 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes R03A / R03AC or go back.
References
Tradenames

Serevent Serevent Beglan · Betamican · Inaspir · Serevent · Soltel Serevent Salmetedur · Serevent Serevent Neovent · Salmeterol · Serevent · Soltel · Vertine Salmeterol · Serevent Serevent Asmetic · Pulmoterol · Pulveril · Serevent Serevent Serevent Serevent Salmeterol · Serevent Salmeterol · Serevent Serevent Serevent Serevent Serevent Beglan · Neovent · Serevent · Soltel · Vertine Salmeterol
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙